PSquared Asset Management AG Buys Tiffany, The Medicines Co, Qiagen NV, Sells Versum Materials Inc, Spark Therapeutics Inc, Medidata Solutions Inc

Author's Avatar
[email protected]
Feb 14, 2020
Article's Main Image
Investment company PSquared Asset Management AG (Current Portfolio) buys Tiffany, The Medicines Co, Qiagen NV, sells Versum Materials Inc, Spark Therapeutics Inc, Medidata Solutions Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, PSquared Asset Management AG. As of 2019Q4, PSquared Asset Management AG owns 7 stocks with a total value of $550 million. These are the details of the buys and sells.

For the details of PSquared Asset Management AG's stock buys and sells, go to https://www.gurufocus.com/guru/psquared+asset+management+ag/current-portfolio/portfolio

These are the top 5 holdings of PSquared Asset Management AG
  1. Cypress Semiconductor Corp (CY) - 8,013,563 shares, 33.99% of the total portfolio. Shares reduced by 4.32%
  2. Allergan PLC (AGN) - 907,744 shares, 31.55% of the total portfolio. Shares added by 15.26%
  3. Zayo Group Holdings Inc (ZAYO) - 2,223,072 shares, 14.01% of the total portfolio. Shares added by 6.12%
  4. Tiffany & Co (TIF) - 513,644 shares, 12.48% of the total portfolio. New Position
  5. The Medicines Co (MDCO) - 200,000 shares, 3.09% of the total portfolio. New Position
New Purchase: Tiffany & Co (TIF)

PSquared Asset Management AG initiated holding in Tiffany & Co. The purchase prices were between $86.63 and $133.8, with an estimated average price of $119.09. The stock is now traded at around $134.29. The impact to a portfolio due to this purchase was 12.48%. The holding were 513,644 shares as of .

New Purchase: The Medicines Co (MDCO)

PSquared Asset Management AG initiated holding in The Medicines Co. The purchase prices were between $49.68 and $84.94, with an estimated average price of $67.5. The stock is now traded at around $84.90. The impact to a portfolio due to this purchase was 3.09%. The holding were 200,000 shares as of .

New Purchase: Qiagen NV (QGEN)

PSquared Asset Management AG initiated holding in Qiagen NV. The purchase prices were between $25.41 and $43.1, with an estimated average price of $35.32. The stock is now traded at around $37.17. The impact to a portfolio due to this purchase was 1.86%. The holding were 303,250 shares as of .

Sold Out: Versum Materials Inc (VSM)

PSquared Asset Management AG sold out a holding in Versum Materials Inc. The sale prices were between $52.97 and $52.99, with an estimated average price of $52.98.

Sold Out: Spark Therapeutics Inc (ONCE)

PSquared Asset Management AG sold out a holding in Spark Therapeutics Inc. The sale prices were between $96.25 and $113.57, with an estimated average price of $107.51.

Sold Out: Medidata Solutions Inc (MDSO)

PSquared Asset Management AG sold out a holding in Medidata Solutions Inc. The sale prices were between $91.48 and $92.24, with an estimated average price of $91.87.



Here is the complete portfolio of PSquared Asset Management AG. Also check out:

1. PSquared Asset Management AG's Undervalued Stocks
2. PSquared Asset Management AG's Top Growth Companies, and
3. PSquared Asset Management AG's High Yield stocks
4. Stocks that PSquared Asset Management AG keeps buying
Rating:
0 / 5 (0 votes)